
Spyre Therapeutics, Inc.
USD73.52
+4.36 (+6.30%)
CEO
Cameron Turtle
IPO Date
2016-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$70.05
Prev. Close
$69.16
Day Low
$69.81
Day High
$76.11
52W Low
$13.93
52W High
$78.80
Market Cap
$4.44B
Volume
1.58M
| Deutsche Bank |
| Buy |
| Buy |
| maintain |
| 14 Apr 2026 | Wedbush | Outperform | Outperform | maintain |
| 14 Apr 2026 | Baird | Outperform | Outperform | maintain |
| 14 Apr 2026 | Wells Fargo | Overweight | Overweight | maintain |
| 13 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |
| 13 Apr 2026 | BTIG | Buy | Buy | maintain |
| 13 Apr 2026 | Jefferies | Buy | Buy | maintain |